Table 3.
Study | Type | Patients EUBD/PTBD (n) | EUS site puncture EUHGS/EUCD | Technical success (%) | Clinical success (%) | Adverse events EUBD/PTBD (%) | Reintervention EUBD/PTBD (%) | LOS EUBD/PTBD (days) |
---|---|---|---|---|---|---|---|---|
Artifon et al.21 | Prospective | 13/12 | 0/12 | 100/100 | 100/100 | 15/25 | N/A | N/A |
Bapaye et al.22 | Retrospective | 25/26 | 13/10 | 92/46 | N/A | 20/46 | N/A | N/A |
Khashab et al.23 | Retrospective | 22/51 | 3/19 | 86/100 | 86/92 | 18/39 | 15/80 | N/A |
Lee et al.24 | Prospective | 34/32 | 25/9 | 94/96 | 87/87 | 8/31 | 25/54 | 6/12 |
Current study | Retrospective | 31/20 | 31/0 | 100/100 | 86/83 | 16/10 | 6/100 | 8/15 |
EUBD, endosonography-guided biliary drainage; PTBD, percutaneous transhepatic biliary drainage; EUCD, endosonography-guided choledochoduodenostomy; EUHGS, endosonography-guided hepaticogastrostomy; LOS, length of hospital stay; N/A, data not available.